Investigating Psychosocial Experiences of HIV Cure Trial Participants Undergoing Extended HIV Treatment Interruptions: Implications for Ethical Conduct

调查长期艾滋病毒治疗中断的艾滋病毒治疗试验参与者的心理社会经历:对道德行为的影响

基本信息

  • 批准号:
    10647752
  • 负责人:
  • 金额:
    $ 69.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

7. PROJECT SUMMARY/ABSTRACT HIV cure research is a high-priority for the National Institutes of Health and is targeting a strategy that can lead to sustained antiretroviral treatment (ART)-free suppression. However, because there are no clear biomarkers for an HIV cure – unlike CD4+ count and viral load as markers of ART efficacy – the only way to evaluate the efficacy of a strategy is to require otherwise healthy people living with HIV (PLWH) who have achieved viral suppression to pause their ART. This pausing is called an analytical treatment interruption (ATI) and is the most controversial aspect of HIV cure research. Further, to advance HIV cure research, participants are required to tolerate extended ATIs, which are long periods of high levels of uncontrolled viremia. The goals of the proposed research are to investigate the informed consent process and participants' understanding and experiences with extended ATIs, and use a robust consensus-building technique to resolve the most pressing ethical challenges in HIV cure research. Aims 1 – 2 are nested within four entirely unique trials across the U.S. with a combined total of 120 participants. The studies are taking place through the AIDS Clinical Trials Group Network (ACTG) and the University of California, San Francisco (UCSF). Aim 1 will evaluate the quality of informed consent in 30 participants going through an ATI study, and survey data will be collected measuring perceived benefits, risks, understanding of study procedures, expectations, and relevant psychosocial domains (e.g., HIV stigma, resilience). Aims 2 will prospectively evaluate the psychosocial experiences, quantitatively and qualitatively, of HIV cure research participants before, during and after ATIs. This involves the analysis of strategically placed, and fully integrated prospective psychosocial survey assessments and interviews from study entry to exit. Surveys include measures of anxiety-related outcomes to monitor potential for psychological harm and stress levels during the ATI (among other domains). In addition, Aim 3 involves the use of a hybrid Delphi process to build consensus for strategies to address evolving ethical challenges in HIV cure research. A panel of experts are selected from across the U.S. to engage in four rounds of surveys, with community partners providing input on survey results in between rounds. The goal is to hone in on consensus around how to address racial and ethnic differences and medical mistrust as a barrier to engagement in HIV cure research (including women living with HIV), how to implement ATIs safely, how to address psychosocial harms, and how to protect sexual partners during ATIs. The proposed aims will show how people living with HIV understand and experience cutting-edge HIV cure strategies that can only be evaluated through extended ATIs. The potential impact of this research will result in concrete sets of recommendations and actionable items to enhance the informed consent process to reduce consent misunderstanding, report on any psychosocial harms and development of risk mitigation plans, and set guidance on implementation of HIV cure research centering on needs of priority populations.
7.项目摘要/摘要 艾滋病毒治疗研究是美国国立卫生研究院的一个高度优先事项, 持续的抗逆转录病毒治疗(ART)免费抑制。然而,由于没有明确的生物标志物, 与作为ART疗效标志的CD 4+计数和病毒载量不同, 一项战略的有效性是要求在其他方面健康的艾滋病毒感染者(PLWH) 这种暂停被称为分析性治疗中断(ATI), 艾滋病治疗研究的争议方面。此外,为了推进艾滋病毒治疗研究,要求参与者 耐受延长的ATI,这是长时间的高水平不受控制的病毒血症。拟议的目标 研究是调查知情同意过程和参与者的理解和经验, 扩展ATI,并使用强大的共识建立技术来解决最紧迫的道德挑战 艾滋病治疗研究目标1 - 2嵌套在美国四个完全独特的试验中, 共有120名参与者。这些研究是通过艾滋病临床试验小组网络(ACTG)进行的 和加州大学弗朗西斯科分校(UCSF)。目标1将评估30个国家的知情同意质量 参与者通过ATI研究,调查数据将收集测量感知的好处,风险, 了解研究程序、期望和相关的心理社会领域(例如,艾滋病污名化, 弹性)。目标2将从定量和定性两个方面前瞻性地评估下列人员的心理社会经验: 艾滋病毒治疗研究参与者在ATI之前,期间和之后。这涉及到分析战略地位, 从研究进入到退出,完全整合了前瞻性心理社会调查评估和访谈。 调查包括焦虑相关结果的测量,以监测潜在的心理伤害和压力 在ATI期间的级别(以及其他域)。此外,Aim 3还涉及使用混合德尔菲过程, 就应对艾滋病毒治疗研究中不断变化的伦理挑战的战略达成共识。一个专家小组 从美国各地选出参与四轮调查,由社区合作伙伴提供意见 在两轮之间的调查结果。目标是围绕如何解决种族和 种族差异和医学上的不信任是参与艾滋病毒治疗研究的障碍(包括生活在 艾滋病毒感染者),如何安全地实施ATI,如何解决心理社会危害,以及如何保护性伴侣 在ATI期间。拟议的目标将展示艾滋病毒感染者如何理解和体验尖端的 艾滋病毒治疗策略只能通过扩展的ATI进行评估。这项研究的潜在影响将 产生一套具体的建议和可采取行动的项目,以加强知情同意程序, 减少对同意的误解,报告任何社会心理伤害并制定风险缓解计划, 制定了以重点人群需求为中心开展艾滋病治愈研究的指导方针。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States
  • DOI:
    10.1080/25787489.2024.2312318
  • 发表时间:
    2024-01-29
  • 期刊:
  • 影响因子:
    1.6
  • 作者:
    Dube,Karine;Ndukwe,Samuel O.;Sauceda,John A.
  • 通讯作者:
    Sauceda,John A.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karine Dube其他文献

Karine Dube的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karine Dube', 18)}}的其他基金

Integrating Trauma-Informed Research in Assessment of Young Women Engaged in HIV Cure Research (Post-Intervention Control) Trial with Analytical Treatment Interruption in Durban, South Africa
将创伤知情研究纳入南非德班参与艾滋病毒治疗研究(干预后控制)试验的年轻女性与分析治疗中断的评估中
  • 批准号:
    10761531
  • 财政年份:
    2023
  • 资助金额:
    $ 69.46万
  • 项目类别:
Investigating Psychosocial Experiences of HIV Cure Trial Participants Undergoing Extended HIV Treatment Interruptions: Implications for Ethical Conduct
调查长期艾滋病毒治疗中断的艾滋病毒治疗试验参与者的心理社会经历:对道德行为的影响
  • 批准号:
    10325217
  • 财政年份:
    2021
  • 资助金额:
    $ 69.46万
  • 项目类别:
Investigating Psychosocial Experiences of HIV Cure Trial Participants Undergoing Extended HIV Treatment Interruptions: Implications for Ethical Conduct
调查长期艾滋病毒治疗中断的艾滋病毒治疗试验参与者的心理社会经历:对道德行为的影响
  • 批准号:
    10438929
  • 财政年份:
    2021
  • 资助金额:
    $ 69.46万
  • 项目类别:
Perceptions of Risks and Benefits of Participating in HIV Cure-related Research among Diverse Youth and Young Adults Living with HIV in the United States
美国不同的艾滋病毒感染者对参与艾滋病毒治疗相关研究的风险和益处的看法
  • 批准号:
    10011703
  • 财政年份:
    2020
  • 资助金额:
    $ 69.46万
  • 项目类别:
Pilot Integration of Participant-Centered Outcomes in HIV Cure Research in the United States: Implications for Ethical Conduct
美国艾滋病毒治疗研究中以参与者为中心的成果试点整合:对道德行为的影响
  • 批准号:
    9905559
  • 财政年份:
    2019
  • 资助金额:
    $ 69.46万
  • 项目类别:

相似海外基金

SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
  • 批准号:
    2400967
  • 财政年份:
    2024
  • 资助金额:
    $ 69.46万
  • 项目类别:
    Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328975
  • 财政年份:
    2024
  • 资助金额:
    $ 69.46万
  • 项目类别:
    Continuing Grant
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
  • 批准号:
    NE/Y000080/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.46万
  • 项目类别:
    Research Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
  • 批准号:
    10112700
  • 财政年份:
    2024
  • 资助金额:
    $ 69.46万
  • 项目类别:
    Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328973
  • 财政年份:
    2024
  • 资助金额:
    $ 69.46万
  • 项目类别:
    Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328972
  • 财政年份:
    2024
  • 资助金额:
    $ 69.46万
  • 项目类别:
    Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332916
  • 财政年份:
    2024
  • 资助金额:
    $ 69.46万
  • 项目类别:
    Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
  • 批准号:
    2332917
  • 财政年份:
    2024
  • 资助金额:
    $ 69.46万
  • 项目类别:
    Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
  • 批准号:
    2328974
  • 财政年份:
    2024
  • 资助金额:
    $ 69.46万
  • 项目类别:
    Continuing Grant
Radiation GRMHD with Non-Thermal Particle Acceleration: Next-Generation Models of Black Hole Accretion Flows and Jets
具有非热粒子加速的辐射 GRMHD:黑洞吸积流和喷流的下一代模型
  • 批准号:
    2307983
  • 财政年份:
    2023
  • 资助金额:
    $ 69.46万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了